Stryker Corp last reported quarterly results on Oct 29, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $6.5 billion (+7.6% year over year) and diluted EPS of $1.96. It usually reports 29–30 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 28, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Thursday. Based on last year's release for the same quarter on Jan 29, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 29–30 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Oct 29, 2026
29 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
6,520
+7.6%
|
753
-12.3%
|
1.96
-11.7%
|
|
Jul 30, 2026
30 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
6,589
+9.4%
|
1,276
+44.3%
|
3.30
+44.1%
|
|
Apr 30, 2026
30 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
6,020
+2.6%
|
745
+13.9%
|
1.93
+14.2%
|
|
Jan 29, 2026
29 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
7,171
+11.4%
|
849
+55.5%
|
2.20
+56.0%
|
|
Oct 30, 2025
30 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
6,057
+10.2%
|
859
+3.0%
|
2.22
+2.8%
|
|
Jul 31, 2025
31 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
6,022
+11.1%
|
884
+7.2%
|
2.29
+7.0%
|
|
May 1, 2025
31 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
5,866
+11.9%
|
654
-17.0%
|
1.69
-17.6%
|
|
Jan 28, 2025
28 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
6,436
+10.7%
|
546
-52.2%
|
1.41
-52.7%
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- SYK (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- MI
- Headquarters
- Portage, MI
- SEC filer status
- Large accelerated filer
- SEC CIK
- 310764
Other Surgical & Medical Instruments & Apparatus companies
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
- West Pharmaceutical Services Inc WST
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.